About CHUGAI DIGITAL
Chugai is transforming its own business to provide healthcare solutions that will change society by combining unique scientific and technological capabilities through cutting-edge digital technology.
Why Chugai is engaged in digital transformation
Changing the conventional approach to develop new drugs
It can take more than 10 years to develop a single new drug. The probability of success for new drug development is decreasing every year, while development costs are increasing.
Chugai aims to reform the drug discovery process by acquiring and analyzing large amounts of diverse data using cutting-edge digital technologies including AI.
Pursuing patient-centric healthcare
Chugai has been a pioneer in Japan, contributing to the development of personalized healthcare (PHC), where treatment plans are based on a patient’s genetic information.
By combining and analyzing multiple data such as genomic data, real-world data (RWD), and digital biomarkers, we will lead the next generation of PHC to better understand a patient’s condition and provide the optimal treatment for each individual.
CHUGAI DIGITAL VISION 2030
“Chugai is transforming its own business and becoming a top innovator in providing healthcare solutions that will change society through using digital technology.”
Three basic strategies will transform Chugai’s business and provide healthcare solutions that change society.
* DxD3 Digital transformation for Drug Discovery and Development
1 Strengthen the digital platform
In collaboration with the Roche group, we aim to establish a global-level IT infrastructure by integrating various internal data and constructing an analysis platform. In addition, we will actively promote the recruitment and development of digital talents, including data scientists and data engineers, and establish a system that allows employees to freely express their ideas and challenges, thereby establishing a foundation for new value creation.
2 Optimize all value chains
We will use digital technology to dramatically boost the efficiency of each department and function, in particular production and marketing processes. Through a comprehensive analysis of customer data, we will also contribute to the development of new solutions to enhance customer experience.
3 Digital transformation for drug discovery and development (DxD3*)
AI-leveraging drug discovery
Dramatically changing the research process, including the use of AI and other advanced technologies to create new drug candidates and improve the probability of success in drug discovery.
Digital biomarkers (dBM) initiatives
Providing new values based on patient biometric data acquired by the development of digital biomarkers and wearable devices.
Utilization of real-world data (RWD)
Innovating the clinical development process through the analysis of genomic and real-world data (RWD).